Patterson BJ - Search Results

1

Estimated Public Health Impact of the Recombinant Zoster Vaccine.

Patterson BJ, Buck PO, Curran D, Van Oorschot D, Carrico J, Herring WL, Zhang Y, Stoddard JJ. Patterson BJ, et al. Mayo Clin Proc Innov Qual Outcomes. 2021 May 26;5(3):596-604. doi: 10.1016/j.mayocpiqo.2021.03.006. eCollection 2021 Jun. Mayo Clin Proc Innov Qual Outcomes. 2021. PMID: 34195552 Free PMC article.

2

Cost-effectiveness of an Adjuvanted Recombinant Zoster Vaccine in older adults in the United States.

Curran D, Patterson B, Varghese L, Van Oorschot D, Buck P, Carrico J, Hicks K, Lee B, Yawn B. Curran D, et al. Vaccine. 2018 Aug 9;36(33):5037-5045. doi: 10.1016/j.vaccine.2018.07.005. Epub 2018 Jul 14. Vaccine. 2018. PMID: 30017145 Free article.

3

National survey of pharmacy-based immunization services.

Westrick SC, Patterson BJ, Kader MS, Rashid S, Buck PO, Rothholz MC. Westrick SC, et al. Among authors: patterson bj. Vaccine. 2018 Sep 5;36(37):5657-5664. doi: 10.1016/j.vaccine.2018.07.027. Epub 2018 Jul 23. Vaccine. 2018. PMID: 30049631 Free article.

4

Cost-effectiveness of an adjuvanted recombinant zoster vaccine in older adults in the United States who have been previously vaccinated with zoster vaccine live.

Curran D, Patterson BJ, Van Oorschot D, Buck PO, Carrico J, Hicks KA, Lee B, Yawn BP. Curran D, et al. Among authors: patterson bj. Hum Vaccin Immunother. 2019;15(4):765-771. doi: 10.1080/21645515.2018.1558689. Epub 2019 Feb 20. Hum Vaccin Immunother. 2019. PMID: 30625011 Free PMC article.

5

Analysis of Vascular Event Risk After Herpes Zoster From 2007 to 2014 US Insurance Claims Data.

Patterson BJ, Rausch DA, Irwin DE, Liang M, Yan S, Yawn BP. Patterson BJ, et al. Mayo Clin Proc. 2019 May;94(5):763-775. doi: 10.1016/j.mayocp.2018.12.025. Epub 2019 Apr 5. Mayo Clin Proc. 2019. PMID: 30955916 Free article.

6

In reply-Vascular Event Risk After Herpes Zoster.

Patterson BJ, Rausch DA, Irwin DE, Yawn BP. Patterson BJ, et al. Mayo Clin Proc. 2019 Aug;94(8):1650-1651. doi: 10.1016/j.mayocp.2019.05.028. Mayo Clin Proc. 2019. PMID: 31378245 No abstract available.

7

The Epidemiology of Herpes Zoster in Immunocompetent, Unvaccinated Adults ≥50 Years Old: Incidence, Complications, Hospitalization, Mortality, and Recurrence.

Tseng HF, Bruxvoort K, Ackerson B, Luo Y, Tanenbaum H, Tian Y, Zheng C, Cheung B, Patterson BJ, Van Oorschot D, Sy LS. Tseng HF, et al. Among authors: patterson bj. J Infect Dis. 2020 Aug 4;222(5):798-806. doi: 10.1093/infdis/jiz652. J Infect Dis. 2020. PMID: 31830250 Free PMC article.

8

Correspondence regarding Wilson et al., cost-effectiveness of a comprehensive immunization program serving high-risk, uninsured adults.

Patterson BJ, Curran D, Buck PO. Patterson BJ, et al. Prev Med. 2020 Jan 9:105973. doi: 10.1016/j.ypmed.2019.105973. Online ahead of print. Prev Med. 2020. PMID: 32122690 Free article. No abstract available.

9

Incremental clinical and economic impact of recombinant zoster vaccination: real-world data in a budget impact model.

Patterson BJ, Herring WL, Van Oorschot D, Curran D, Carrico J, Zhang Y, Ackerson BK, Bruxvoort K, Sy LS, Tseng HF. Patterson BJ, et al. J Manag Care Spec Pharm. 2020 Dec;26(12):1567-1575. doi: 10.18553/jmcp.2020.20251. Epub 2020 Oct 12. J Manag Care Spec Pharm. 2020. PMID: 33043821 Free PMC article.

10

Early examination of real-world uptake and second-dose completion of recombinant zoster vaccine in the United States from October 2017 to September 2019.

Patterson BJ, Chen CC, McGuiness CB, Glasser LI, Sun K, Buck PO. Patterson BJ, et al. Hum Vaccin Immunother. 2021 Aug 3;17(8):2482-2487. doi: 10.1080/21645515.2021.1879579. Epub 2021 Apr 13. Hum Vaccin Immunother. 2021. PMID: 33849373 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page